Cargando…
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
SARS-CoV-2 infection is characterized by a protean clinical picture that can range from asymptomatic patients to life-threatening conditions. Severe COVID-19 patients often display a severe pulmonary involvement and develop neutrophilia, lymphopenia, and strikingly elevated levels of IL-6. There is...
Autores principales: | Perricone, Carlo, Bartoloni, Elena, Bursi, Roberto, Cafaro, Giacomo, Guidelli, Giacomo Maria, Shoenfeld, Yehuda, Gerli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366458/ https://www.ncbi.nlm.nih.gov/pubmed/32681497 http://dx.doi.org/10.1007/s12026-020-09145-5 |
Ejemplares similares
-
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future
por: Bursi, Roberto, et al.
Publicado: (2021) -
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020) -
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021) -
Acute disseminated encephalomyelitis progressing to multiple sclerosis: Are infectious triggers involved?
por: Smyk, Daniel S., et al.
Publicado: (2014) -
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?
por: Ruscitti, Piero, et al.
Publicado: (2023)